1. |
Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev, 2014, 23(5): 700-713.
|
2. |
Wang W, Li YF, Sun XW, et al. Prognosis of 980 patients with gastric cancer after surgical resection. Chin J Cancer, 2010, 29(11): 923-930.
|
3. |
Lim JB, Chung HW. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer. Cytokine, 2015, 73(1): 16-22.
|
4. |
Khalil DN, Smith EL, Brentjens RJ, et al. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat Rev Clin Oncol, 2016, 13(5): 273-290.
|
5. |
Sasaki A, Nakamura Y, Mishima S, et al. Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer. Gastric Cancer, 2019, 22(4): 793-802.
|
6. |
Binder M, Rajkumar SV, Lacy MQ, et al. Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma. Am J Hematol, 2019, 94(3): 306-311.
|
7. |
Porrata LF, Ristow K, Colgan JP, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma. Haematologica, 2012, 97(2): 262-269.
|
8. |
Eo WK, Jeong DW, Chang HJ, et al. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer. World J Gastroenterol, 2015, 21(9): 2668-2676.
|
9. |
Goto W, Kashiwagi S, Asano Y, et al. Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer. BMC Cancer, 2018, 18(1): 1137. doi: 10.1186/s12885-018-5051-9.
|
10. |
Saito H, Kono Y, Murakami Y, et al. Prognostic significance of pre- and postoperative lymphocyte counts in patients with gastric cancer. Dig Surg, 2019, 36(2): 137-143.
|
11. |
Feng F, Zheng G, Wang Q, et al. Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer. BMC Gastroenterol, 2018, 18(1): 148. doi: 10.1186/s12876-018-0877-9.
|
12. |
Ma JY, Liu Q. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: a meta-analysis. Int J Surg, 2018, 50: 67-71.
|
13. |
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer, 2011, 14(2): 113-123.
|
14. |
Edge SB, American Joint Committee. American cancer, AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York: Springer, 2010: 718.
|
15. |
Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res, 2004, 10(21): 7252-7259.
|
16. |
Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics, 2000, 56(2): 337-344.
|
17. |
Gu L, Li H, Chen L, et al. Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget, 2016, 7(22): 31926-31942.
|
18. |
Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity, 2004, 21(2): 137-148.
|
19. |
赵阳, 程静. 手术前后中性粒细胞淋巴细胞比率变化对评估胃癌患者预后的临床价值. 中国普外基础与临床杂志, 2020, 27(12): 1538-1542.
|
20. |
Azimi F, Scolyer RA, Rumcheva P, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol, 2012, 30(21): 2678-2683.
|
21. |
Augier S, Ciucci T, Luci C, et al. Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillance. J Immunol, 2010, 185(12): 7165-7173.
|
22. |
Galdiero MR, Bonavita E, Barajon I, et al. Tumor associated macrophages and neutrophils in cancer. Immunobiology, 2013, 218(11): 1402-1410.
|
23. |
Lin JX, Lin JP, Xie JW, et al. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer. Gastric Cancer, 2019, 22(2): 403-412.
|
24. |
Deng Q, He B, Liu X, et al. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med, 2015, 13: 66. doi: 10.1186/s12967-015-0409-0.
|
25. |
Fujiwara Y, Misawa T, Shiba H, et al. Postoperative peripheral absolute blood lymphocyte-to-monocyte ratio predicts therapeutic outcome after pancreatic resection in patients with pancreatic adenocarcinoma. Anticancer Res, 2014, 34(9): 5163-5168.
|
26. |
Sekine K, Kanda S, Goto Y, et al. Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer. Lung Cancer, 2018, 124: 179-188.
|
27. |
Galvez-Silva J, Maher OM, Park M, et al. Prognostic analysis of absolute lymphocyte and monocyte counts after autologous stem cell transplantation in children, adolescents, and young adults with refractory or relapsed hodgkin lymphoma. Biol Blood Marrow Transplant, 2017, 23(8): 1276-1281.
|
28. |
Shariat SF, Karakiewicz PI, Suardi N, et al. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res, 2008, 14(14): 4400-4407.
|
29. |
Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol, 2008, 26(8): 1364-1370.
|